However, it should be noted that ablating the gut microbiome either in germ-free mice or mice treated with an antibiotic mix leads to an extraordinary enlarged BA pool and altered BA components, resulting in altered FXR signalling, and contributes to a phenotype that resists HFD-induced metabolic disorders [18]. The gene discussed is NR1H4; the disease is Other metabolic disease.